Next generation immunotherapy for tree pollen allergies

References

• Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108:S2-8. https://doi.org/10.1067/mai.2001.115569. PMID:11449200
   PubMed Web of Science ®Google Scholar
• Yamada T , Saito H , Fujieda S. Present state of Japanese cedar pollinosis: The national affliction. J Allergy Clin Immunol. 2014;133:632-9 e5. https://doi.org/10.1016/j.jaci.2013.11.002. PMID:24361081
   PubMed Web of Science ®Google Scholar
• Floistrup H , Swartz J , Bergstrom A , Alm JS , Scheynius A , van Hage M , et al. Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol. 2006;117:59-66. https://doi.org/10.1016/j.jaci.2005.09.039. PMID:16387585
   PubMed Web of Science ®Google Scholar
• Durham SR , Penagos M . Sublingual or subcutaneous immunotherapy for allergic rhinitis? J Allergy Clin Immunol. 2016;137:339-49 e10. https://doi.org/10.1016/j.jaci.2015.12.1298
   Web of Science ®Google Scholar
• Dretzke J , Meadows A , Novielli N , Huissoon A , Fry-Smith A , Meads C . Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013;131:1361-6. https://doi.org/10.1016/j.jaci.2013.02.013. PMID:23557834
   PubMed Web of Science ®Google Scholar
• Durham SR , Creticos PS , Nelson HS , Li Z , Kaur A , Meltzer EO , et al. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses. J Allergy Clin Immunol. 2016;138:1081-8 e4. https://doi.org/10.1016/j.jaci.2016.04.061
   Web of Science ®Google Scholar
• Okubo K , Gotoh M . Sublingual immunotherapy for Japanese cedar pollinosis. Allergol Int. 2009;58:149-54. https://doi.org/10.2332/allergolint.08-RAI-0072. PMID:19390236
   PubMedGoogle Scholar
• Kiel MA , Roder E , Gerth van Wijk R , Al MJ , Hop WC , Rutten-van Molken MP . Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353-60 e2. https://doi.org/10.1016/j.jaci.2013.03.013. PMID:23651609
   PubMed Web of Science ®Google Scholar
• Jutel M , Bartkowiak-Emeryk M , Breborowicz A , Cichocka-Jarosz E , Emeryk A , Gawlik R , et al. Sublingual immunotherapy (SLIT)–indications, mechanism, and efficacy: Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy. Ann Agric Environ Med. 2016;23:44-53. https://doi.org/10.5604/12321966.1196851. PMID:27012173
   PubMed Web of Science ®Google Scholar
• Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med. 2001;344:30-7. https://doi.org/10.1056/NEJM200101043440106. PMID:11136958
   PubMed Web of Science ®Google Scholar
• Kay AB. Allergy and allergic diseases. Second of two parts. N Engl J Med. 2001;344:109-13. https://doi.org/10.1056/NEJM200101113440206. PMID:11150362
   PubMed Web of Science ®Google Scholar
• Alvaro M , Sancha J , Larramona H , Lucas JM , Mesa M , Tabar AI , et al. Allergen-specific immunotherapy: update on immunological mechanisms. Allergol Immunopathol (Madr). 2013;41:265-72. https://doi.org/10.1016/j.aller.2012.07.018. PMID:23332741
   PubMed Web of Science ®Google Scholar
• Larche M , Akdis CA , Valenta R . Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol. 2006;6:761-71. https://doi.org/10.1038/nri1934. PMID:16998509
   PubMed Web of Science ®Google Scholar
• Akdis CA , Akdis M . Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015;8:17. https://doi.org/10.1186/s40413-015-0063-2. PMID:26023323
   PubMed Web of Science ®Google Scholar
• Akdis CA , Akdis M . Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest. 2014;124:4678-80. https://doi.org/10.1172/JCI78891. PMID:25365074
   PubMed Web of Science ®Google Scholar
• Eberlein-Konig B , Ullmann S , Thomas P , Przybilla B . Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy. 1995;25:704-12. https://doi.org/10.1111/j.1365-2222.1995.tb00007.x. PMID:7584681
   PubMed Web of Science ®Google Scholar
• Francis JN , Till SJ , Durham SR . Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003;111:1255-61. https://doi.org/10.1067/mai.2003.1570. PMID:12789226
   PubMed Web of Science ®Google Scholar
• Yamanaka K , Yuta A , Kakeda M , Sasaki R , Kitagawa H , Gabazza EC , et al. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis. J Allergy Clin Immunol. 2009;124:842-5 e7. https://doi.org/10.1016/j.jaci.2009.06.020. PMID:19703707
   PubMed Web of Science ®Google Scholar
• van de Veen W , Stanic B , Yaman G , Wawrzyniak M , Sollner S , Akdis DG , et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131:1204-12. https://doi.org/10.1016/j.jaci.2013.01.014. PMID:23453135
   PubMed Web of Science ®Google Scholar
• Yamanaka K , Yuta A , Kakeda M , Kitagawa H , Ogihara H , Gabazza EC , et al. SLIT improves cedar pollinosis by restoring IL-10 production from Tr1 and Monocytes approximately IL-10 productivity is critical for becoming allergic approximately. Allergol Int. 2011;60:45-51. https://doi.org/10.2332/allergolint.10-OA-0198. PMID:21099249
   PubMedGoogle Scholar
• Nouri-Aria KT , Wachholz PA , Francis JN , Jacobson MR , Walker SM , Wilcock LK , et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172:3252-9. https://doi.org/10.4049/jimmunol.172.5.3252. PMID:14978133
   PubMed Web of Science ®Google Scholar
• Okamoto Y , Horiguchi S , Yamamoto H , Yonekura S , Hanazawa T . Present situation of cedar pollinosis in Japan and its immune responses. Allergol Int. 2009;58:155-62. https://doi.org/10.2332/allergolint.08-RAI-0074. PMID:19307773
   PubMedGoogle Scholar
• Nomura T , Suzuki M , Yokota M , Nakamura Y , Ozeki K , Ito Y , et al. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood. Ann Allergy Asthma Immunol. 2016;117:72-8 e4. https://doi.org/10.1016/j.anai.2016.04.003
   Web of Science ®Google Scholar
• Suarez-Fueyo A , Ramos T , Galan A , Jimeno L , Wurtzen PA , Marin A , et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol. 2014;133:130-8 e1-2. https://doi.org/10.1016/j.jaci.2013.09.043
   PubMed Web of Science ®Google Scholar
• Gleich GJ , Zimmermann EM , Henderson LL , Yunginger JW . Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study. J Allergy Clin Immunol. 1982;70:261-71. https://doi.org/10.1016/0091-6749(82)90062-8. PMID:6811645
   PubMed Web of Science ®Google Scholar
• Reisinger J , Horak F , Pauli G , van Hage M , Cromwell O , Konig F , et al. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol. 2005;116:347-54. https://doi.org/10.1016/j.jaci.2005.04.003. PMID:16083789
   PubMed Web of Science ®Google Scholar
• Jutel M , Jaeger L , Suck R , Meyer H , Fiebig H , Cromwell O . Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116:608-13. https://doi.org/10.1016/j.jaci.2005.06.004. PMID:16159631
   PubMed Web of Science ®Google Scholar
• James LK , Shamji MH , Walker SM , Wilson DR , Wachholz PA , Francis JN , et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 2011;127:509-16 e1-5. https://doi.org/10.1016/j.jaci.2010.12.1080
   Web of Science ®Google Scholar
• van Neerven RJ, Wikborg T , Lund G , Jacobsen B , Brinch-Nielsen A , Arnved J , et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol. 1999;163:2944-52. PMID:10453043
   PubMed Web of Science ®Google Scholar
• Wachholz PA , Soni NK , Till SJ , Durham SR . Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol. 2003;112:915-22. https://doi.org/10.1016/S0091-6749(03)02022-0. PMID:14610480
   PubMed Web of Science ®Google Scholar
• Asam C , Hofer H , Wolf M , Aglas L , Wallner M . Tree pollen allergens-an update from a molecular perspective. Allergy. 2015;70:1201-11. https://doi.org/10.1111/all.12696. PMID:26186076
   PubMed Web of Science ®Google Scholar
• Pablos I , Wildner S , Asam C , Wallner M , Gadermaier G . Pollen Allergens for Molecular Diagnosis. Curr Allergy Asthma Rep. 2016;16:31. https://doi.org/10.1007/s11882-016-0603-z. PMID:27002515
   PubMed Web of Science ®Google Scholar
• D'Amato G , Cecchi L , Bonini S , Nunes C , Annesi-Maesano I , Behrendt H , et al. Allergenic pollen and pollen allergy in Europe. Allergy. 2007;62:976-90. https://doi.org/10.1111/j.1398-9995.2007.01393.x. PMID:17521313
   PubMed Web of Science ®Google Scholar
• Burbach GJ , Heinzerling LM , Edenharter G , Bachert C , Bindslev-Jensen C , Bonini S , et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64:1507-15. https://doi.org/10.1111/j.1398-9995.2009.02089.x. PMID:19772516
   PubMed Web of Science ®Google Scholar
• Ipsen H , Lowenstein H . Isolation and immunochemical characterization of the major allergen of birch pollen (Betula verrucosa). J Allergy Clin Immunol. 1983;72:150-9. https://doi.org/10.1016/0091-6749(83)90523-7. PMID:6886253
   PubMed Web of Science ®Google Scholar
• Jarolim E , Rumpold H , Endler AT , Schlerka G , Ebner H , Scheiner O , et al. Specificities of IgE and IgG antibodies in patients with birch pollen allergy. Int Arch Allergy Appl Immunol. 1989;88:180-2. https://doi.org/10.1159/000234778. PMID:2707881
   PubMedGoogle Scholar
• Yasueda H , Yui Y , Shimizu T , Shida T . Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol. 1983;71:77-86. https://doi.org/10.1016/0091-6749(83)90550-X. PMID:6822692
   PubMed Web of Science ®Google Scholar
• Sakaguchi M , Inouye S , Taniai M , Ando S , Usui M , Matuhasi T . Identification of the second major allergen of Japanese cedar pollen. Allergy. 1990;45:309-12. https://doi.org/10.1111/j.1398-9995.1990.tb00501.x. PMID:2382797
   PubMed Web of Science ®Google Scholar
• Hashimoto M , Nigi H , Sakaguchi M , Inouye S , Imaoka K , Miyazawa H , et al. Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin Exp Allergy. 1995;25:848-52. https://doi.org/10.1111/j.1365-2222.1995.tb00027.x. PMID:8564723
   PubMed Web of Science ®Google Scholar
• Sugimura K , Hashiguchi S , Takahashi Y , Hino K , Taniguchi Y , Kurimoto M , et al. Th1/Th2 response profiles to the major allergens Cry j 1 and Cry j 2 of Japanese cedar pollen. Allergy. 1996;51:732-40. PMID:8905002
   PubMed Web of Science ®Google Scholar
• Marsh DG , Lichtenstein LM , Campbell DH . Studies on “allergoids” prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology. 1970;18:705-22. PMID:4192674
   PubMed Web of Science ®Google Scholar
• Baldridge JR , McGowan P , Evans JT , Cluff C , Mossman S , Johnson D , et al. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther. 2004;4:1129-38. https://doi.org/10.1517/14712598.4.7.1129. PMID:15268679
   PubMed Web of Science ®Google Scholar
• Drachenberg KJ , Heinzkill M , Urban E , Woroniecki SR . Efficacy and tolerability of short-term specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A (MPL) for children and adolescents. Allergol Immunopathol (Madr). 2003;31:270-7. https://doi.org/10.1016/S0301-0546(03)79195-2. PMID:14572416
   PubMedGoogle Scholar
• Drachenberg KJ , Wheeler AW , Stuebner P , Horak F . A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy. 2001;56:498-505. https://doi.org/10.1034/j.1398-9995.2001.056006498.x. PMID:11421893
   PubMed Web of Science ®Google Scholar
• Rosewich M , Schulze J , Eickmeier O , Telles T , Rose MA , Schubert R , et al. Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. Clin Exp Immunol. 2010;160:403-10. https://doi.org/10.1111/j.1365-2249.2010.04106.x. PMID:20345983
   PubMed Web of Science ®Google Scholar
• Rosewich M , Lee D , Zielen S . Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother. 2013;9:1523-31. https://doi.org/10.4161/hv.24631. PMID:23584250
   PubMed Web of Science ®Google Scholar
• Mothes N , Heinzkill M , Drachenberg KJ , Sperr WR , Krauth MT , Majlesi Y , et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy. 2003;33:1198-208. https://doi.org/10.1046/j.1365-2222.2003.01699.x. PMID:12956739
   PubMed Web of Science ®Google Scholar
• Takagi H , Furuya N , Kojima N . Preferential production of IL-12 by peritoneal macrophages activated by liposomes prepared from neoglycolipids containing oligomannose residues. Cytokine. 2007;40:241-50. https://doi.org/10.1016/j.cyto.2007.10.005. PMID:18060800
   PubMed Web of Science ®Google Scholar
• Kojima N , Ishii M , Kawauchi Y , Takagi H . Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status. Biomed Res Int. 2013;2013:562924. https://doi.org/10.1155/2013/562924. PMID:24224170
   PubMed Web of Science ®Google Scholar
• Ishii M , Koyama A , Iseki H , Narumi H , Yokoyama N , Kojima N . Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice. Int Immunopharmacol. 2010;10:1041-6. https://doi.org/10.1016/j.intimp.2010.06.003. PMID:20584630
   PubMed Web of Science ®Google Scholar
• Sun S , Kishimoto H , Sprent J . DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med. 1998;187:1145-50. https://doi.org/10.1084/jem.187.7.1145. PMID:9529331
   PubMed Web of Science ®Google Scholar
• Kaburaki Y , Fujimura T , Kurata K , Masuda K , Toda M , Yasueda H , et al. Induction of Th1 immune responses to Japanese cedar pollen allergen (Cry j 1) in mice immunized with Cry j 1 conjugated with CpG oligodeoxynucleotide. Comp Immunol Microbiol Infect Dis. 2011;34:157-61. https://doi.org/10.1016/j.cimid.2010.06.005. PMID:20638725
   PubMed Web of Science ®Google Scholar
• Suzuki M , Ohta N , Min WP , Matsumoto T , Min R , Zhang X , et al. Immunotherapy with CpG DNA conjugated with T-cell epitope peptide of an allergenic Cry j 2 protein is useful for control of allergic conditions in mice. Int Immunopharmacol. 2007;7:46-54. https://doi.org/10.1016/j.intimp.2006.08.010. PMID:17161816
   PubMed Web of Science ®Google Scholar
• Focke M , Marth K , Flicker S , Valenta R . Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy. 2008;38:1400-8. https://doi.org/10.1111/j.1365-2222.2008.03031.x. PMID:18564332
   PubMed Web of Science ®Google Scholar
• Focke M , Marth K , Valenta R . Molecular composition and biological activity of commercial birch pollen allergen extracts. Eur J Clin Invest. 2009;39:429-36. https://doi.org/10.1111/j.1365-2362.2009.02109.x. PMID:19302561
   PubMed Web of Science ®Google Scholar
• Moverare R , Elfman L , Vesterinen E , Metso T , Haahtela T . Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy. 2002;57:423-30. https://doi.org/10.1034/j.1398-9995.2002.13248.x. PMID:11972482
   PubMed Web of Science ®Google Scholar
• Valenta R , Ferreira F , Focke-Tejkl M , Linhart B , Niederberger V , Swoboda I , et al. From allergen genes to allergy vaccines. Annu Rev Immunol. 2010;28:211-41. https://doi.org/10.1146/annurev-immunol-030409-101218. PMID:20192803
   PubMed Web of Science ®Google Scholar
• Pauli G , Larsen TH , Rak S , Horak F , Pastorello E , Valenta R , et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2008;122:951-60. https://doi.org/10.1016/j.jaci.2008.09.017. PMID:19000581
   PubMed Web of Science ®Google Scholar
• Nony E , Bouley J , Le Mignon M, Lemoine P , Jain K , Horiot S , et al. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Allergy. 2015;70:795-804. https://doi.org/10.1111/all.12622. PMID:25846209
   PubMed Web of Science ®Google Scholar
• van Hage-Hamsten M, Johansson E , Roquet A , Peterson C , Andersson M , Greiff L , et al. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis. Clin Exp Allergy. 2002;32:1448-53. https://doi.org/10.1046/j.1365-2745.2002.01495.x. PMID:12372124
   PubMed Web of Science ®Google Scholar
• Gafvelin G , Thunberg S , Kronqvist M , Gronlund H , Gronneberg R , Troye-Blomberg M , et al. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1. Int Arch Allergy Immunol. 2005;138:59-66. https://doi.org/10.1159/000087358. PMID:16103688
   PubMed Web of Science ®Google Scholar
• Campana R , Vrtala S , Maderegger B , Jertschin P , Stegfellner G , Swoboda I , et al. Hypoallergenic derivatives of the major birch pollen allergen Bet v 1 obtained by rational sequence reassembly. J Allergy Clin Immunol. 2010;126:1024-31, 31 e1-8. https://doi.org/10.1016/j.jaci.2010.05.023
   Web of Science ®Google Scholar
• Niederberger V , Horak F , Vrtala S , Spitzauer S , Krauth MT , Valent P , et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A. 2004;101 Suppl 2:14677-82. https://doi.org/10.1073/pnas.0404735101. PMID:15310844
   PubMed Web of Science ®Google Scholar
• Pauli G , Purohit A , Oster JP , De Blay F, Vrtala S , Niederberger V , et al. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population. Clin Exp Allergy. 2000;30:1076-84. https://doi.org/10.1046/j.1365-2222.2000.00869.x. PMID:10931114
   PubMed Web of Science ®Google Scholar
• Purohit A , Niederberger V , Kronqvist M , Horak F , Gronneberg R , Suck R , et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy. 2008;38:1514-25. https://doi.org/10.1111/j.1365-2222.2008.03042.x. PMID:18564326
   PubMed Web of Science ®Google Scholar
• Campana R , Moritz K , Marth K , Neubauer A , Huber H , Henning R , et al. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments. J Allergy Clin Immunol. 2016;137:601-9 e8. https://doi.org/10.1016/j.jaci.2015.08.042
   Web of Science ®Google Scholar
• Haselden BM , Kay AB , Larche M . Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med. 1999;189:1885-94. https://doi.org/10.1084/jem.189.12.1885. PMID:10377184
   PubMed Web of Science ®Google Scholar
• Fellrath JM , Kettner A , Dufour N , Frigerio C , Schneeberger D , Leimgruber A , et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol. 2003;111:854-61. https://doi.org/10.1067/mai.2003.1337. PMID:12704369
   PubMed Web of Science ®Google Scholar
• Kammerer R , Kettner A , Chvatchko Y , Dufour N , Tiercy JM , Corradin G , et al. Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy. Clin Exp Allergy. 1997;27:1016-26. https://doi.org/10.1111/j.1365-2222.1997.tb01253.x. PMID:9678833
   PubMed Web of Science ®Google Scholar
• Kammerer R , Chvatchko Y , Kettner A , Dufour N , Corradin G , Spertini F . Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy. J Allergy Clin Immunol. 1997;100:96-103. https://doi.org/10.1016/S0091-6749(97)70200-8. PMID:9257793
   PubMed Web of Science ®Google Scholar
• Pellaton C , Perrin Y , Boudousquie C , Barbier N , Wassenberg J , Corradin G , et al. Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides. Clin Transl Allergy. 2013;3:17. https://doi.org/10.1186/2045-7022-3-17. PMID:23725004
   PubMedGoogle Scholar
• Spertini F , Perrin Y , Audran R , Pellaton C , Boudousquie C , Barbier N , et al. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. J Allergy Clin Immunol. 2014;134:239-40 e13. https://doi.org/10.1016/j.jaci.2014.04.001
   Web of Science ®Google Scholar
• Spertini F , DellaCorte G , Kettner A , de Blay F , Jacobsen L , Jutel M , et al. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. J Allergy Clin Immunol. 2016;138:162-8. https://doi.org/10.1016/j.jaci.2016.02.044. PMID:27373329
   PubMed Web of Science ®Google Scholar
• Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol. 2007;119:906-9. https://doi.org/10.1016/j.jaci.2007.02.015. PMID:17418662
   PubMed Web of Science ®Google Scholar
• Couroux P , Patel D , Armstrong K , Larche M , Hafner RP . Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects. Clin Exp Allergy. 2015;45:974-81. https://doi.org/10.1111/cea.12488. PMID:25600085
   PubMed Web of Science ®Google Scholar
• Ellis AK , Frankish CW , O'Hehir RE , Armstrong K , Steacy L , Larché M , Hafner RP. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2017;140:486-96. https://doi.org/10.1016/j.jaci.2016.11.043. PMID:28236469
   PubMed Web of Science ®Google Scholar
• Valenta R , Campana R , Focke-Tejkl M , Niederberger V . Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 2016;137:351-7. https://doi.org/10.1016/j.jaci.2015.12.1299. PMID:26853127
   PubMed Web of Science ®Google Scholar
• Vrtala S , Hirtenlehner K , Vangelista L , Pastore A , Eichler HG , Sperr WR , et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J Clin Invest. 1997;99:1673-81. https://doi.org/10.1172/JCI119330. PMID:9120011
   PubMed Web of Science ®Google Scholar
• Valenta R , Campana R , Niederberger V . Recombinant allergy vaccines based on allergen-derived B cell epitopes. Immunol Lett. 2017; [Epub ahead of print]. https://doi.org/10.1016/j.imlet.2017.04.015. PMID:28472641
   PubMed Web of Science ®Google Scholar
• Zieglmayer P , Focke-Tejkl M , Schmutz R , Lemell P , Zieglmayer R , Weber M , et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine. 2016;11:43-57. https://doi.org/10.1016/j.ebiom.2016.08.022. PMID:27650868
   PubMed Web of Science ®Google Scholar
• Focke M , Linhart B , Hartl A , Wiedermann U , Sperr WR , Valent P , et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy. 2004;34:1525-33. https://doi.org/10.1111/j.1365-2222.2004.02081.x. PMID:15479266
   PubMed Web of Science ®Google Scholar
• Focke M , Mahler V , Ball T , Sperr WR , Majlesi Y , Valent P , et al. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J. 2001;15:2042-4. PMID:11511525
   PubMed Web of Science ®Google Scholar
• Cornelius C , Schoneweis K , Georgi F , Weber M , Niederberger V , Zieglmayer P , et al. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection. EBioMedicine. 2016;11:58-67. https://doi.org/10.1016/j.ebiom.2016.07.023. PMID:27568223
   PubMed Web of Science ®Google Scholar
• Niespodziana K , Focke-Tejkl M , Linhart B , Civaj V , Blatt K , Valent P , et al. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS. J Allergy Clin Immunol. 2011;127:1562-70 e6. https://doi.org/10.1016/j.jaci.2011.02.004. PMID:21411130
   PubMed Web of Science ®Google Scholar
• Marth K , Breyer I , Focke-Tejkl M , Blatt K , Shamji MH , Layhadi J , et al. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype. J Immunol. 2013;190:3068-78. https://doi.org/10.4049/jimmunol.1202441. PMID:23440415
   PubMed Web of Science ®Google Scholar
• Linhart B , Narayanan M , Focke-Tejkl M , Wrba F , Vrtala S , Valenta R . Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy. 2014;44:278-87. https://doi.org/10.1111/cea.12216. PMID:24447086
   PubMed Web of Science ®Google Scholar
• Cox L , Nelson H , Lockey R , Calabria C , Chacko T , Finegold I , et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127:S1-55. https://doi.org/10.1016/j.jaci.2010.09.034. PMID:21122901
   PubMed Web of Science ®Google Scholar
• Fujimura T , Fujinami K , Ishikawa R , Tateno M , Tahara Y , Okumura Y , et al. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys. Int Arch Allergy Immunol. 2015;168:32-43. https://doi.org/10.1159/000441141. PMID:26524293
   PubMed Web of Science ®Google Scholar
• Wolff JA , Malone RW , Williams P , Chong W , Acsadi G , Jani A , et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465-8. https://doi.org/10.1126/science.1690918. PMID:1690918
   PubMed Web of Science ®Google Scholar
• Tang DC , DeVit M , Johnston SA . Genetic immunization is a simple method for eliciting an immune response. Nature. 1992;356:152-4. https://doi.org/10.1038/356152a0. PMID:1545867
   PubMed Web of Science ®Google Scholar
• Ulmer JB , Donnelly JJ , Parker SE , Rhodes GH , Felgner PL , Dwarki VJ , et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993;259:1745-9. https://doi.org/10.1126/science.8456302. PMID:8456302
   PubMed Web of Science ®Google Scholar
• Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev. 2011;239:62-84. https://doi.org/10.1111/j.1600-065X.2010.00980.x. PMID:21198665
   PubMed Web of Science ®Google Scholar
• Lu S , Wang S , Grimes-Serrano JM . Current progress of DNA vaccine studies in humans. Expert Rev Vaccines. 2008;7:175-91. https://doi.org/10.1586/14760584.7.2.175. PMID:18324888
   PubMed Web of Science ®Google Scholar
• Chua KY , Kuo IC , Huang CH . DNA vaccines for the prevention and treatment of allergy. Curr Opin Allergy Clin Immunol. 2009;9:50-4. https://doi.org/10.1097/ACI.0b013e3283207ad8. PMID:19532092
   PubMed Web of Science ®Google Scholar
• Hsu CH , Chua KY , Tao MH , Lai YL , Wu HD , Huang SK , et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med. 1996;2:540-4. https://doi.org/10.1038/nm0596-540. PMID:8616712
   PubMed Web of Science ®Google Scholar
• Tan LK , Huang CH , Kuo IC , Liew LM , Chua KY . Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production. Vaccine. 2006;24:5762-71. https://doi.org/10.1016/j.vaccine.2006.04.064. PMID:16740347
   PubMed Web of Science ®Google Scholar
• Peng HJ , Su SN , Chang ZN , Chao PL , Kuo SW , Tsai LC . Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11. Vaccine. 2002;20:1761-8. https://doi.org/10.1016/S0264-410X(02)00029-4. PMID:11906763
   PubMed Web of Science ®Google Scholar
• Raz E , Tighe H , Sato Y , Corr M , Dudler JA , Roman M , et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A. 1996;93:5141-5. https://doi.org/10.1073/pnas.93.10.5141. PMID:8643542
   PubMed Web of Science ®Google Scholar
• Hartl A , Kiesslich J , Weiss R , Bernhaupt A , Mostbock S , Scheiblhofer S , et al. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J Allergy Clin Immunol. 1999;103:107-13. https://doi.org/10.1016/S0091-6749(99)70533-6. PMID:9893193
   PubMed Web of Science ®Google Scholar
• Hartl A , Hochreiter R , Stepanoska T , Ferreira F , Thalhamer J . Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a. Allergy. 2004;59:65-73. https://doi.org/10.1046/j.1398-9995.2003.00335.x. PMID:14674936
   PubMed Web of Science ®Google Scholar
• Toda M , Sato H , Takebe Y , Taniguchi Y , Saito S , Inouye S , et al. Inhibition of immunoglobulin E response to Japanese cedar pollen allergen (Cry j 1) in mice by DNA immunization: different outcomes dependent on the plasmid DNA inoculation method. Immunology. 2000;99:179-86. https://doi.org/10.1046/j.1365-2567.2000.00935.x. PMID:10692034
   PubMed Web of Science ®Google Scholar
• Toda M , Kasai M , Hosokawa H , Nakano N , Taniguchi Y , Inouye S , et al. DNA vaccine using invariant chain gene for delivery of CD4+ T cell epitope peptide derived from Japanese cedar pollen allergen inhibits allergen-specific IgE response. Eur J Immunol. 2002;32:1631-9. https://doi.org/10.1002/1521-4141(200206)32:6%3c1631::AID-IMMU1631%3e3.0.CO;2-O. PMID:12115646
   PubMed Web of Science ®Google Scholar
• Weinberger EE , Isakovic A , Scheiblhofer S , Ramsauer C , Reiter K , Hauser-Kronberger C , et al. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine. Vaccine. 2013;31:6113-21. https://doi.org/10.1016/j.vaccine.2013.08.005. PMID:23954383
   PubMed Web of Science ®Google Scholar
• Chen JW , Cha Y , Yuksel KU , Gracy RW , August JT . Isolation and sequencing of a cDNA clone encoding lysosomal membrane glycoprotein mouse LAMP-1. Sequence similarity to proteins bearing onco-differentiation antigens. J Biol Chem. 1988;263:8754-8. PMID:3379044
   PubMed Web of Science ®Google Scholar
• Andrejewski N , Punnonen EL , Guhde G , Tanaka Y , Lullmann-Rauch R , Hartmann D , et al. Normal lysosomal morphology and function in LAMP-1-deficient mice. J Biol Chem. 1999;274:12692-701. https://doi.org/10.1074/jbc.274.18.12692. PMID:10212251
   PubMed Web of Science ®Google Scholar
• Rowell JF , Ruff AL , Guarnieri FG , Staveley-O'Carroll K , Lin X , Tang J , et al. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J Immunol. 1995;155:1818-28. PMID:7636236
   PubMed Web of Science ®Google Scholar
• Ruff AL , Guarnieri FG , Staveley-O'Carroll K , Siliciano RF , August JT . The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. J Biol Chem. 1997;272:8671-8. https://doi.org/10.1074/jbc.272.13.8671. PMID:9079699
   PubMed Web of Science ®Google Scholar
• Wu TC , Guarnieri FG , Staveley-O'Carroll KF , Viscidi RP , Levitsky HI , Hedrick L , et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci U S A. 1995;92:11671-5. https://doi.org/10.1073/pnas.92.25.11671. PMID:8524826
   PubMed Web of Science ®Google Scholar
• Su Y , Connolly M , Marketon A , Heiland T . CryJ-LAMP DNA Vaccines for Japanese Red Cedar Allergy Induce Robust Th1-Type Immune Responses in Murine Model. J Immunol Res. 2016;2016:4857869. https://doi.org/10.1155/2016/4857869. PMID:27239481
   PubMed Web of Science ®Google Scholar
• Su Y , Romeu-Bonilla E , Anagnostou A , Fitz-Patrick D , Hearl W , Heiland T . Safety and Long-Term Immunological Effects of CryJ2-LAMP Plasmid Vaccine in Japanese Red Cedar Atopic Subjects: A phase I study. Hum Vaccin Immunother. 2017; [Epub ahead of print]. https://doi.org/10.1080/21645515.2017.1329070
   Web of Science ®Google Scholar
• Vickery BP , Scurlock AM , Jones SM , Burks AW . Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol. 2011;127:576-84; quiz 85-6. https://doi.org/10.1016/j.jaci.2010.12.1116. PMID:21277624
   PubMed Web of Science ®Google Scholar
• Bjorksten B , Moller C , Broberger U , Ahlstedt S , Dreborg S , Johansson SG , et al. Clinical and immunological effects of oral immunotherapy with a standardized birch pollen extract. Allergy. 1986;41:290-5. https://doi.org/10.1111/j.1398-9995.1986.tb02031.x. PMID:3752420
   PubMed Web of Science ®Google Scholar
• Moller C , Dreborg S , Lanner A , Bjorksten B . Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Allergy. 1986;41:271-9. https://doi.org/10.1111/j.1398-9995.1986.tb02028.x. PMID:3530030
   PubMed Web of Science ®Google Scholar
• Usui M , Saito A , Taniguchi N , Nishijima N , Azakami H , Kato A . Reduction of antigenicity of Cry j I, major allergen of Japanese cedar pollen, by the attachment of polysaccharides. Biosci Biotechnol Biochem. 2003;67:2425-30. https://doi.org/10.1271/bbb.67.2425. PMID:14646203
   PubMed Web of Science ®Google Scholar
• Aoki R , Saito A , Azakami H , Kato A . Effects of various saccharides on the masking of epitope sites and uptake in the gut of cedar allergen Cry j 1-saccharide conjugates by a naturally occurring Maillard reaction. J Agric Food Chem. 2010;58:7986-90. https://doi.org/10.1021/jf100793d. PMID:20527985
   PubMed Web of Science ®Google Scholar
• Murakami D , Kubo K , Sawatsubashi M , Kikkawa S , Ejima M , Saito A , et al. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis. Auris Nasus Larynx. 2014;41:350-8. https://doi.org/10.1016/j.anl.2014.02.010. PMID:24698163
   PubMed Web of Science ®Google Scholar
• Murakami D , Sawatsubashi M , Kikkawa S , Ejima M , Saito A , Kato A , et al. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study. Allergol Int. 2015;64:161-8. https://doi.org/10.1016/j.alit.2014.10.009. PMID:25838092
   PubMed Web of Science ®Google Scholar
• Murakami D , Sawatsubashi M , Omori H , Saito A , Kato A , Komune S , et al. Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial. Sci Rep. 2017;7:46142. https://doi.org/10.1038/srep46142. PMID:28397833
   PubMed Web of Science ®Google Scholar
• Murakami D , Sawatsubashi M , Kikkawa S , Ejima M , Saito A , Kato A , et al. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study. Auris Nasus Larynx. 2016;43:50-5. https://doi.org/10.1016/j.anl.2015.06.011. PMID:26197940
   PubMed Web of Science ®Google Scholar
• Takaiwa F. Update on the use of transgenic rice seeds in oral immunotherapy. Immunotherapy. 2013;5:301-12. https://doi.org/10.2217/imt.13.4. PMID:23444957
   PubMed Web of Science ®Google Scholar
• Takagi H , Hiroi T , Yang L , Tada Y , Yuki Y , Takamura K , et al. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses. Proc Natl Acad Sci U S A. 2005;102:17525-30. https://doi.org/10.1073/pnas.0503428102. PMID:16278301
   PubMed Web of Science ®Google Scholar
• Takagi H , Saito S , Yang L , Nagasaka S , Nishizawa N , Takaiwa F . Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine. Plant Biotechnol J. 2005;3:521-33. https://doi.org/10.1111/j.1467-7652.2005.00143.x. PMID:17173638
   PubMed Web of Science ®Google Scholar
• Yang L , Suzuki K , Hirose S , Wakasa Y , Takaiwa F . Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy. Plant Biotechnol J. 2007;5:815-26. https://doi.org/10.1111/j.1467-7652.2007.00287.x. PMID:17714439
   PubMed Web of Science ®Google Scholar
• Wakasa Y , Takagi H , Hirose S , Yang L , Saeki M , Nishimura T , et al. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis. Plant Biotechnol J. 2013;11:66-76. https://doi.org/10.1111/pbi.12007. PMID:23066780
   PubMed Web of Science ®Google Scholar
• Wang S , Takahashi H , Kajiura H , Kawakatsu T , Fujiyama K , Takaiwa F . Transgenic rice seeds accumulating recombinant hypoallergenic birch pollen allergen Bet v 1 generate giant protein bodies. Plant Cell Physiol. 2013;54:917-33. https://doi.org/10.1093/pcp/pct043. PMID:23539245
   PubMed Web of Science ®Google Scholar
• Yang L , Hirose S , Suzuki K , Hiroi T , Takaiwa F . Expression of hypoallergenic Der f 2 derivatives with altered intramolecular disulphide bonds induces the formation of novel ER-derived protein bodies in transgenic rice seeds. J Exp Bot. 2012;63:2947-59. https://doi.org/10.1093/jxb/ers006. PMID:22378952
   PubMed Web of Science ®Google Scholar
• Wakasa Y , Takagi H , Watanabe N , Kitamura N , Fujiwara Y , Ogo Y , et al. Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy-a new mucosal vaccine formulation against Japanese cedar pollen allergy. PLoS One. 2015;10:e0120209. https://doi.org/10.1371/journal.pone.0120209. PMID:25774686
   PubMed Web of Science ®Google Scholar
• Hirahara K , Saito S , Serizawa N , Sasaki R , Sakaguchi M , Inouye S , et al. Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice. J Allergy Clin Immunol. 1998;102:961-7. https://doi.org/10.1016/S0091-6749(98)70334-3. PMID:9847437
   PubMed Web of Science ®Google Scholar
• Murasugi T , Nakagami Y , Yoshitomi T , Hirahara K , Yamashita M , Taniguchi Y , et al. Oral administration of a T cell epitope inhibits symptoms and reactions of allergic rhinitis in Japanese cedar pollen allergen-sensitized mice. Eur J Pharmacol. 2005;510:143-8. https://doi.org/10.1016/j.ejphar.2005.01.003. PMID:15740735
   PubMed Web of Science ®Google Scholar
• Yoshitomi T , Hirahara K , Kawaguchi J , Serizawa N , Taniguchi Y , Saito S , et al. Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide. Immunology. 2002;107:517-22. https://doi.org/10.1046/j.1365-2567.2002.01534.x. PMID:12460197
   PubMed Web of Science ®Google Scholar
• Kawabe Y , Hayashida Y , Numata K , Harada S , Hayashida Y , Ito A , et al. Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens. PLoS One. 2012;7:e48512. https://doi.org/10.1371/journal.pone.0048512. PMID:23144766
   PubMed Web of Science ®Google Scholar
• Martinez-Gomez JM , Johansen P , Erdmann I , Senti G , Crameri R , Kundig TM . Intralymphatic injections as a new administration route for allergen-specific immunotherapy. Int Arch Allergy Immunol. 2009;150:59-65. https://doi.org/10.1159/000210381. PMID:19339803
   PubMed Web of Science ®Google Scholar
• Senti G , Prinz Vavricka BM , Erdmann I , Diaz MI , Markus R , McCormack SJ , et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A. 2008;105:17908-12. https://doi.org/10.1073/pnas.0803725105. PMID:19001265
   PubMed Web of Science ®Google Scholar
• Senti G , Crameri R , Kuster D , Johansen P , Martinez-Gomez JM , Graf N , et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol. 2012;129:1290-6. https://doi.org/10.1016/j.jaci.2012.02.026. PMID:22464647
   PubMed Web of Science ®Google Scholar
• Hylander T , Latif L , Petersson-Westin U , Cardell LO . Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol. 2013;131:412-20. https://doi.org/10.1016/j.jaci.2012.10.056. PMID:23374268
   PubMed Web of Science ®Google Scholar
• Hylander T , Larsson O , Petersson-Westin U , Eriksson M , Kumlien Georen S , Winqvist O , et al. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. Respir Res. 2016;17:10. https://doi.org/10.1186/s12931-016-0324-9. PMID:26817454
   PubMed Web of Science ®Google Scholar
• Senti G , von Moos S , Kundig TM . Epicutaneous Immunotherapy for Aeroallergen and Food Allergy. Curr Treat Options Allergy. 2014;1:68-78. https://doi.org/10.1007/s40521-013-0003-8. PMID:24918342
   PubMedGoogle Scholar
• Senti G , Graf N , Haug S , Ruedi N , von Moos S , Sonderegger T , et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol. 2009;124:997-1002. https://doi.org/10.1016/j.jaci.2009.07.019. PMID:19733905
   PubMed Web of Science ®Google Scholar
• Jones SM , Sicherer SH , Burks AW , Leung DY , Lindblad RW , Dawson P , et al. Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults. J Allergy Clin Immunol. 2017;139:1242-52 e9. https://doi.org/10.1016/j.jaci.2016.08.017
   Web of Science ®Google Scholar
• Senti G , von Moos S , Tay F , Graf N , Johansen P , Kundig TM . Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70:707-10. https://doi.org/10.1111/all.12600. PMID:25704072
   PubMed Web of Science ®Google Scholar
• Jones SM , Agbotounou WK , Fleischer DM , Burks AW , Pesek RD , Harris MW , et al. Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch. J Allergy Clin Immunol. 2016;137:1258-61 e1-10. https://doi.org/10.1016/j.jaci.2016.01.008
   Web of Science ®Google Scholar
• von Moos S, Johansen P , Tay F , Graf N , Kundig TM , Senti G . Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy. J Allergy Clin Immunol. 2014;134:965-7 e4. https://doi.org/10.1016/j.jaci.2014.07.037. PMID:25282570
   PubMed Web of Science ®Google Scholar
• Dioszeghy V , Mondoulet L , Dhelft V , Ligouis M , Puteaux E , Dupont C , et al. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice. Clin Exp Allergy. 2014;44:867-81. https://doi.org/10.1111/cea.12312. PMID:24666588
   PubMed Web of Science ®Google Scholar
• Siebeneicher S , Reuter S , Krause M , Wangorsch A , Maxeiner J , Wolfheimer S , et al. Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model. Allergy. 2014;69:328-37. https://doi.org/10.1111/all.12326. PMID:24329861
   PubMed Web of Science ®Google Scholar
• Siebeneicher S , Reuter S , Wangorsch A , Krause M , Foetisch K , Heinz A , et al. Epicutaneous immunotherapy with a hypoallergenic Bet v 1 suppresses allergic asthma in a murine model. Allergy. 2015;70:1559-68. https://doi.org/10.1111/all.12732. PMID:26304061
   PubMed Web of Science ®Google Scholar
• Cabauatan CR , Campana R , Niespodziana K , Reinisch C , Lundberg U , Meinke A , et al. Heat-labile Escherichia coli toxin enhances the induction of allergen-specific IgG antibodies in epicutaneous patch vaccination. Allergy. 2017;72:164-8. https://doi.org/10.1111/all.13036. PMID:27568860
   PubMed Web of Science ®Google Scholar